CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban
Conclusion Higher CHA2DS2-VASc scores are associated with increased incidence of major bleeding in nonvalvular atrial fibrillation patients receiving rivaroxaban.
Source: Annals of Emergency Medicine - Category: Emergency Medicine Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Congestive Heart Failure | Diabetes | Diabetes Mellitus | Electronic Medical Records (EMR) | Emergency Medicine | Endocrinology | Heart | Heart Failure | Hypertension | Ischemic Stroke | Stroke | Study | Thrombosis